SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Goldman Sachs upgrade to Buy, citing sovereign-AI demand and growth in customized software, is reinforcing Palantirs AI growth story as the stock reaches fresh highs. Bulls are celebrating the breakout and speculating about a short squeeze, while skeptics warn that the valuation is stretched and the rally could pull back.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile shares sold off sharply after SpaceX agreed to acquire low-band spectrum for Starlink Mobile, raising fears that it could eventually compete with established wireless carriers. Traders are divided between seeing a lasting competitive threat and viewing the reaction as excessive, arguing that building a capable terrestrial network would take substantial time and investment.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRKs sharp rally is drawing attention to Starknets privacy and Bitcoin DeFi push, including strkBTC and STRK20, alongside its post-quantum security narrative. Traders are largely bullish on the technology and momentum, while some remain wary of token unlocks and selling pressure.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoins choppy pullback and struggle to break above a key psychological level are driving discussion, with many traders describing weak or stagnant price action and warning of further downside. Others view the dip as an accumulation opportunity and expect a rebound alongside broader crypto-market strength.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canadas sharp selloff and underperformance versus U.S. airline peers are driving discussion, with traders citing oil and fuel-cost uncertainty and speculating about shorting or selling pressure after the share bid. Bears see further downside, while bulls point to buybacks and Aeroplans value as reasons for optimism.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

A report of a planned NIH-backed push to accelerate personalized cancer vaccines has lifted vaccine stocks, including BioNTech. Traders are discussing the sector rally and BioNTechs oncology pipeline, while some question why BNTX is lagging Moderna.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

AMZNs sharp rally has traders focused on whether it can break through the closely watched $260 area, with bullish chatter around heavy call buying and a potential technical breakout. Others warn the move could stall or retrace, pointing to resistance and the stocks choppy trading.

Fortinet, Inc. provides cybersecurity solutions to a variety of businesses, such as enterprises, communication service providers, government organizations, and small to medium-sized businesses. Its product portfolio includes network security, secure access service edge, enterprise networking, security operations, application security, and operational technology. The company was founded by Ken Xie and Michael Xie in November 2000 and is headquartered in Sunnyvale, CA.

Fortinet Inc

Fortinet is drawing attention amid a strong cybersecurity-sector rally, with traders linking demand to AI-related security risks and noting its run to new highs. The community is split between bullish momentum views and concerns that stretched valuations and light trading volume could leave the move vulnerable to a pullback.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyagers sharp selloff and persistent underperformance versus other space stocks dominate the discussion, with traders blaming financing and potential dilution concerns around a convertible-note offering. Bearish frustration over management and cash use contrasts with some traders viewing the decline as a buying opportunity.

WorldFinancial

Discussion centers on the OCCs preliminary conditional approval for a World Liberty trust bank tied to its USD1 stablecoin, which bullish traders see as a potential source of utility and demand for WLFI. Skeptics counter that the token has lagged other crypto assets and raise concerns about Trump-family monetization and selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Indian companies invest USD 20.5 billion in US, pharma tops

… Embassy & Consulates in India. The pharmaceutical sector accounted for the vast majority … ;s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Granules India Ltd, Jubilant … Group, Lupin Limited, Piramal Pharma Ltd., and Zydus Lifesciences Limited …

Guardant Health to launch blood-based cancer test in India with Zydus Lifesciences

Guardant Health is set to introduce a groundbreaking blood test in India for early cancer detection. This multi-cancer test, developed with Zydus Lifesciences, aims to identify various cancers like lung, breast, and prostate. The initiative targets India's high cancer burden and low screening rates.

US sales may drag pharma companies’ Q4, even as India holds up

Cipla, Dr Reddy’s Laboratories, and Zydus Lifesciences are among the most affected by the US sales decline.

Semaglutide Ruling Sparks Generic Pharma Boom

… oncology drugs . India's revocation of Novartis … Natco Pharma to launch its version of Roche … Natco Pharma to launch a generic version of Roche … Zydus Lifesciences, Natco Pharma , Alkem Laboratories, and Torrent Pharmaceuticals have developed …

Brief Indonesia: The Great Petrodollar Pivot: Tracing the Trillions Flowing Away From US Debt and more

In this briefing: The Great Petrodollar Pivot: Tracing the Trillions Flowing Away From US Debt Asian Equities: Notwithstanding the Global Turmoil, EPS Estimates Are Surprisingly Strong Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma 1. The Great Petrodollar Pivot: Tracing the Trillions Flowing Away From US Debt The petrodollar equation mandated pricing oil exclusively in US dollars, which exporters recycled into US Treasuries, structurally cementing the dollar's global dominance This system recently fractured because the 1974 agreement expired, and nations are aggressively diversifying their reserves to insulate against Western financial sanctions Middle East still controls crucial oil chokepoints, surplus capital now flows into global petroleum equities rather than traditional US government debt 2.

Why are pharma companies racing to launch semaglutide in India?

… including Zydus Lifesciences, Glenmark Pharmaceuticals , Dr. Reddy’s … belongs to a class of drugs known as GLP-1 … lead to complications. “These drugs are not magic bullets … based in Mumbai. For pharmaceutical companies, semaglutide represents both …

Brief Thailand: Asian Equities: Notwithstanding the Global Turmoil, EPS Estimates Are Surprisingly Strong and more

In this briefing: Asian Equities: Notwithstanding the Global Turmoil, EPS Estimates Are Surprisingly Strong Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift Thailand Short Interest Weekly (Mar 20th): True, Intouch, Thaifoods, CH. Karnchang, Srisawad, True Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma 1. Asian Equities: Notwithstanding the Global Turmoil, EPS Estimates Are Surprisingly Strong Since the beginning of the Iran War, the MSCI Asia ex Japan index has declined 12%. But remarkably, consensus EPS estimate for Asia ex Japan has increased 1.42%. The earnings upgrades are led by Korea, Indonesia, Taiwan and China. Technology, energy, process industries and basic materials figure prominently among the top 20 sectors with upgrades. Consumer services and retail figure prominently among the sectors with largest downgrades. Analysts seem complacent about disruption to tech hardware, process industries and basic materials from energy and input shortages. 2.

Brief Indonesia: Asian Equities: Notwithstanding the Global Turmoil, EPS Estimates Are Surprisingly Strong and more

In this briefing: Asian Equities: Notwithstanding the Global Turmoil, EPS Estimates Are Surprisingly Strong Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma Primer: PP London Sumatra Indonesia (LSIP IJ) - Mar 2026 1. Asian Equities: Notwithstanding the Global Turmoil, EPS Estimates Are Surprisingly Strong Since the beginning of the Iran War, the MSCI Asia ex Japan index has declined 12%. But remarkably, consensus EPS estimate for Asia ex Japan has increased 1.42%. The earnings upgrades are led by Korea, Indonesia, Taiwan and China. Technology, energy, process industries and basic materials figure prominently among the top 20 sectors with upgrades. Consumer services and retail figure prominently among the sectors with largest downgrades. Analysts seem complacent about disruption to tech hardware, process industries and basic materials from energy and input shortages. 2.

Brief Singapore: Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift and more

In this briefing: Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift Dezign Format Group Limited: Results Update AvePoint Inc. Results Update Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma 1. Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift Oil & gas shock drives inflation higher; yields and USD surge, suppressing gold & dilver despite geopolitical risk. Markets remain in an inflation regime; equities are correcting in an orderly manner, not in panic—energy & defence sector, and liquidity dominates positioning. Key pivot is real yields; once they peak, expect rotation into gold & silver, duration, and deeper downside in equities. 2. Dezign Format Group Limited: Results Update FY2025 did not show a collapse in activity. Revenue fell only 1.0% to S$33.1m, and the company still delivered more than S$28m from its core Event, Exhibition and Décor business.

Brief Thailand: Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift and more

In this briefing: Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift Thailand Short Interest Weekly (Mar 20th): True, Intouch, Thaifoods, CH. Karnchang, Srisawad, True Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma Primer: Advanced Info Service (ADVANC TB) - Mar 2026 1. Inflation Shock, Not Fear: Navigating the New Cross-Asset Regime Shift Oil & gas shock drives inflation higher; yields and USD surge, suppressing gold & dilver despite geopolitical risk. Markets remain in an inflation regime; equities are correcting in an orderly manner, not in panic—energy & defence sector, and liquidity dominates positioning. Key pivot is real yields; once they peak, expect rotation into gold & silver, duration, and deeper downside in equities. 2. Thailand Short Interest Weekly (Mar 20th): True, Intouch, Thaifoods, CH. Karnchang, Srisawad, True We analyzed the changes in short interest of Stock Exchange of Thailand as of Mar 20th.

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

Current Price	1,117.50
Prev Close	1,112.00
Open	1,112.00
Dividend Yield	0.11%
50-Day Moving Average	1,145.44
Beta	-0.01
Avg. Volume	1.5M
PE Ratio	24.91

52-Week High	1,232.10
52-Week Low	835.50
Market Capitalization	1.11T
EPS (Annual)	50.09
Price to Book	4.15
Revenue Per Employee	7.34M

Feed

News

Sentiment

Earnings

Fundamentals

Info

ZYDUSLIFE.NSE Fundamentals